Jean E F Rivier

This inventor holds 20 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 4 EPO patents, primarily in Neuropeptide Research. Top assignees: The Salk Institute, Research Development Foundation, Universitât Bern. Active years: 2001-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean E F Rivier. Retrieved from https://idiyas.com/inventor/jean-e-f-rivier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 4)

% Patents Active = 60.0

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 146(Granted Patents)

Company Filing History:

Research Development Foundation

University Hospital Basel

patent

5. 1 out of 1,689

University of Utah Research Foundation

patents

6. 2 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2017

Loading Chart...

Areas of Expertise:

Urocortin

Somatostatin

CRF Antagonists

Neuropeptides

Selective Ligands

Peptide Analogues

GnRH Antagonists

Conotoxins

Receptor Antagonists

Cyclic CRF

Protein Uses

Nucleic Acid Encoding

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9572866 - Urocortin 2 analogs and uses thereof (2017-02-21),

2. 9388229 - Urocortin-III and uses thereof (2016-07-12),

3. 9035022 - Cyclic CRF antagonist peptides (2015-05-19),

4. 8691761 - Somatostatin receptor 2 antagonists (2014-04-08),

5. 8669092 - Urocortin-III and uses thereof (2014-03-11),

6. 8501687 - Receptor(SSTR2)-selective somatostatin antagonists (2013-08-06),

7. 7960342 - Receptor(SSTR2)-selective somatostatin antagonists (2011-06-14),

8. 7851588 - CRFR1 selective ligands (2010-12-14),

9. 7638607 - Urocortin proteins and uses thereof (2009-12-29),

10. 7498300 - CRFR1 selective ligands (2009-03-03),

11. 7238775 - Receptor(SSTR4)-selective somatostatin analogs (2007-07-03),

12. 7223846 - Urocortin proteins and uses thereof (2007-05-29),

13. 7141546 - CRFR2 selective ligands (2006-11-28),

14. RE39240 - Conotoxins I (2006-08-14),

15. 7019109 - SSTR1-selective analogs (2006-03-28),

Title: Jean E F Rivier: Pioneering Inventor from La Jolla

Introduction: Jean E F Rivier is a renowned inventor based in La Jolla, California, known for her groundbreaking contributions to the field of biotechnology and pharmaceuticals.

Latest Patents: Jean E F Rivier holds several patents related to novel drug delivery systems and therapeutic compounds designed to treat a variety of medical conditions.

Career Highlights: With a career spanning over three decades, Jean E F Rivier has worked tirelessly to develop innovative solutions that have the potential to revolutionize the healthcare industry. Her work has been recognized globally for its impact and ingenuity.

Collaborations: Throughout her career, Jean E F Rivier has collaborated with leading researchers, scientists, and pharmaceutical companies to bring her inventions to life. Her collaborative spirit has been instrumental in the success of many projects.

Conclusion: Jean E F Rivier's passion for innovation and dedication to improving human health through her inventions make her a true pioneer in the field. Her contributions continue to inspire the next generation of inventors and researchers.

Profile summary based on public USPTO records.